{"nct_id":"NCT05131204","title":"Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria","status":"TERMINATED","status_verified_date":"2025-04","start_date":"2022-10-06","start_date_type":"ACTUAL","primary_completion_date":"2023-07-12","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["REGN"]}